FDA Drug recall D-0594-2026
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-…
- FDA Drug
- Class II
- ongoing
- Published 2026-06-24
On 2026-06-24 the FDA classified a Class II recall of Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-… by Ajanta Pharma Usa, citing product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0594-2026 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2026-05-27 |
| Published | 2026-06-24 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Ajanta Pharma Usa |
| Distribution | US |
Product
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.
Reason
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Identifiers
| ndc | 27241-051-03 |
|---|---|
| ndc | 27241-051-08 |
| ndc | 27241-052-03 |
| ndc | 27241-052-08 |
| ndc | 27241-053-03 |
| ndc | 27241-053-08 |
| ndc | 27241-054-03 |
| ndc | 27241-054-08 |
| ndc | 27241-055-03 |
| ndc | 27241-055-08 |
| ndc | 27241-056-03 |
| ndc | 27241-056-08 |
| code_info | Lot: PA00805, expires: 01/31/2029 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0594-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.